Latest News
US FDA extends review timeline for AstraZeneca's camizestrant application
27 May 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) announced on Wednesday that the US Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act decision date for camizestrant to allow revie...
Circio and AaviGen partner to develop next-generation gene therapies for heart disease
27 May 2026 - Biotechnology companies Circio Holding ASA (OSE:CRNA) and AaviGen GmbH on Wednesday announced a research collaboration to develop circVec-enhanced AAV vectors engineered for targeted, low-dose gene therapy for heart disease.This partner...
Orsini to chosen as contracted specialty pharmacy for Gilead's Hepcludex (bulevirtide-gmod)
27 May 2026 - Rare disease pharmacy solutions provider Orsini announced on Tuesday that it is the contracted specialty pharmacy for Gilead's Hepcludex (bulevirtide-gmod) 8.5 mg, a subcutaneous injection for the treatment of chronic hepatitis del...
ILC Dover adds Water for Injection (WFI) and custom chemical solutions to offerings
27 May 2026 - ILC Dover, an Ingersoll Rand business involved in design and production for biopharmaceutical, pharmaceutical, and medical device markets, announced on Tuesday that it recently invested in two new core capabilities: Water for Injection ...
CordenPharma acquires AmbioPharm, expanding peptide API capacity
27 May 2026 - CordenPharma, a Switzerland-based global Contract Development and Manufacturing Organisation (CDMO), announced on Wednesday that it has entered into an agreement to acquire AmbioPharm, a US-headquartered peptide Active Pharmaceutical In...